Holiday Message From Dr. Felix Leung
Dear Members of the Ontario Rheumatology Association, As the holiday season approaches, I wanted to take a moment to wish you all a happy and safe holiday season. I hope that you are […]
Biosimilar Transition Policy Announcement in Ontario
On December 20, 2022 the Ontario Ministry of Health announced that effective March 31, 2023, a transition policy will be implemented to expand the use of biosimilar medicines within the public drug program. […]
ORADE Grants Are Back!
The mandate of the Ontario Rheumatology Association Development and Education Committee (ORADE) is to support ORA members and AHP colleagues in their professional development by offering educational grants. Following a 2-year pause due […]
New Biosimilar Fact Sheet Now Available!
The ORA Government Affairs Committee have created a useful tool that organizes biosimilars and their various features, including formulations and LU Codes. You may find the new resource here: Biosimilars […]
Sad News About the Passing of Dr. Vincent Mak
A message from ORA President, Dr. Felix Leung: It is with great difficulty that I must inform you of the sudden passing of our friend and colleague, Dr. Vincent Mak, on Wednesday, August […]
Diversity, Equity and Inclusion Within the ORA
The ORA leadership team recently developed a Diversity, Equity and Inclusion statement that was approved by the Board of Directors. We invite you to scroll down to the bottom of our homepage to […]
Updated ORA Position Statement: Biosimilar Switching
The ORA has recently updated its position statement on biosimilar switching. It is available here: Updated ORA Position Statement Biosimilar Switching […]
Greetings From the New ORA President!
Greetings! I’d like to introduce myself to you as the new President of the Ontario Rheumatology Association. I am very excited to be leading such an important professional association! I have been with […]
Drug Shortages Update – Message from the Canadian Rheumatology Association
The Canadian Rheumatology Association (CRA) has been recently notified by members across the country of shortages in certain medications that are integral to patient care. The CRA has previously responded to alerts […]
Lancet Study: Vaccine Effectiveness Amongst Ontario Patients With Immune-Mediated Inflammatory Diseases
The full article is available here: The Lancet Rheumatology […]
